What is the Nexus Criteria?
The nexus criteria are not a formally defined set of standards in medical literature; rather, establishing a causal link between workplace exposure and a medical condition relies on a systematic evaluation of three core elements: (1) clinical evidence demonstrating a temporal relationship between exposure and symptoms, (2) documented workplace exposure to known causative agents, and (3) objective physiological confirmation of the disease process related to work.
Framework for Establishing Work-Relatedness
The approach to establishing causation between workplace exposure and disease, particularly for conditions like occupational asthma, follows a structured algorithmic process rather than a checklist:
1. Temporal Relationship (Primary Requirement)
- Symptoms must onset or worsen during work exposure and improve during periods away from work 1
- Upper airway and ocular symptoms often precede lower airway symptoms and serve as harbingers 1
- Pattern recognition is critical: symptoms starting shortly after work shift begins, worsening during shift, or resolving on days off or vacations 1
- Caveat: With sensitizer-induced conditions, delayed responses may extend into the next work shift, making temporal patterns less clear 1
2. Exposure Documentation
Identify and document specific workplace exposures through:
- Material Safety Data Sheets (MSDSs) - though these have limitations and may not identify sensitizers or low-concentration exposures (<1%) 1
- Industrial hygiene measurements when available
- Known causative agents (e.g., diisocyanates, animal proteins, wood dusts, metal salts) 1
- Direct communication with workplace safety personnel, always with patient concurrence 1
3. Objective Physiological Confirmation
The diagnostic hierarchy prioritizes:
Gold Standard Approach:
- Serial peak expiratory flow (PEF) measurements: minimum 3 weeks of usual work exposure with measurements ≥4 times daily, or 8 work days and 3 rest days with 2-hourly measurements 2
- Specific inhalation challenge (SIC) tests come closest to a gold standard for many agents 2
- Pre- and post-shift spirometry (FEV₁) for suspected pharmacologic bronchoconstrictors 1
Supporting Evidence:
- Immunologic testing (skin prick tests, specific IgE) - highly sensitive for high molecular weight agents but not specific for diagnosis 2
- Changes in nonspecific airway responsiveness (methacholine testing) after 2+ weeks away from work compared to several weeks on the job 1
- Sputum eosinophils increasing by >1% post-challenge may support diagnosis when FEV₁ falls <20% 2
Critical Pitfalls to Avoid
Early vs. Late Disease Recognition:
- Early detection is crucial - likelihood of recovery is greatest with prompt recognition and exposure control 1
- If exposure continues, nonspecific airway responsiveness increases and remains elevated, making the work-relationship less clear as many substances both in and out of workplace can trigger symptoms 1
Testing Limitations:
- Normal exhaled nitric oxide cannot exclude occupational disease 2
- Presence or absence of sputum eosinophils is not useful for screening 2
- A negative specific inhalation challenge does not exclude diagnosis when other evidence is strong 2
- All lung function and inflammatory markers may be normal in confirmed cases 2
When Consultation is Required
Refer to occupational medicine specialists when:
- Pattern of symptoms or airflow limitation relative to work is unclear 1
- Specialized immunologic or pulmonary function testing is needed
- Academic occupational clinics or NIOSH-funded Education and Research Centers can provide comprehensive evaluation 1
Degree of Proof Required
The level of certainty needed depends on consequences:
- Job loss likely: Require physiological confirmation AND specific agent identification 2
- Relocation possible without income loss: Precise diagnosis less critical 2
- Legal compensation criteria vary by jurisdiction and may not align with clinical diagnosis 2
The key principle: Testing must occur while the patient is still exposed to the suspected cause, making it the first confirmatory step 2.